Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Ранг среди акций
#4354
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Цена акции
$2.41
Рыночная капитализация
$3.61B
Изменение (1 день)
-0.60%
Изменение (1 год)
-10.36%
Страна
CN
Торговля Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Категория
Healthcare
Прибыль Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Прибыль на Jun 2026 TTM: $116.37M
Согласно последним финансовым отчетам Zhejiang Huahai Pharmaceutical Co., Ltd., текущая прибыль компании составляет $116.37M. В 2023 году компания получила прибыль $155.44M, меньше, чем прибыли за 2022, которая составила $218.75M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Zhejiang Huahai Pharmaceutical Co., Ltd. с 2000 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $116.37M | -41.96% |
| 2024 | $200.52M | 29.00% |
| 2023 | $155.44M | -28.94% |
| 2022 | $218.75M | 76.68% |
| 2021 | $123.81M | -33.45% |
| 2020 | $186.04M | 70.26% |
| 2019 | $109.27M | 378.00% |
| 2018 | $22.86M | -80.91% |
| 2017 | $119.77M | 46.64% |
| 2016 | $81.68M | 1.26% |
| 2015 | $80.66M | 59.65% |
| 2014 | $50.52M | -25.67% |
| 2013 | $67.97M | 5.47% |
| 2012 | $64.44M | 48.73% |
| 2011 | $43.33M | 123.78% |
| 2010 | $19.36M | -32.37% |
| 2009 | $28.63M | 16.51% |
| 2008 | $24.57M | -5.07% |
| 2007 | $25.88M | 35.84% |
| 2006 | $19.05M | -12.70% |
| 2005 | $21.83M | 10.70% |
| 2004 | $19.72M | 36.00% |
| 2003 | $14.50M | 63.58% |
| 2002 | $8.86M | 36.52% |
| 2001 | $6.49M | 2.99% |
| 2000 | $6.30M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,416.29% |
IN
|
